 But after the Recombinant Human Coagulation Factor VIII for injection ADVATE Patient Assistance ProgramGolden Key was launched in 24 Apr 2014 in Nanjing China, the affordability of patients was solved and many patients will get more chance to receive standard prophylaxis. 